Preparation modification strategies for clinical treatment drugs of Parkinson's disease

Meng-jiao HE; Yi-fang XIAO; Xiang-an-ni KONG; Zhi-hao LIU; Xiao-guang WANG; Hao FENG; Jia-sheng TU; Qian CHEN; Chun-meng SUN.
Acta Pharmaceutica Sinica ; (12): 574-580, 2024.
Artículo en Zh | WPRIM | ID: wpr-1016626

Documentos relacionados

  1. Levodopa Dose Equivalency in Parkinson's Disease: Updated Systematic Review and Proposals.
  2. Should continuous dopaminergic stimulation be a standard of care in advanced Parkinson's disease?
  3. Inhaled levodopa for threatening impending OFF episodes in managing Parkinson's disease.
  4. Cell-therapy for Parkinson's disease: a systematic review and meta-analysis.
  5. Levodopa infusion therapies for Parkinson disease.
  6. L-DOPA for Parkinson's disease-a bittersweet pill.
  7. Biosensor Strip for Rapid On-site Assessment of Levodopa Pharmacokinetics along with Motor Performance in Parkinson's Disease.
  8. Apprends-moi l'art des petits pas: Levodopa, Carbidopa Intestinal Gel plus Entacapone.
  9. Voltammetric Determination of Levodopa Using Mesoporous Carbon-Modified Screen-Printed Carbon Sensors.
  10. Vitamins and Infusion of Levodopa-Carbidopa Intestinal Gel.